Rossari Biotech has informed that the meeting of the Board of Directors of the Company is scheduled on 20/01/2024 ,inter alia, to consider and approve Unaudited Financial Results (Standalone and Consolidated) for the quarter and nine months ended December, 31, 2023.
The above information is a part of company’s filings submitted to BSE.